USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA Repair.
Animals
Apoptosis
Biomarkers, Tumor
/ genetics
Carcinogenesis
/ genetics
Cell Proliferation
DNA Damage
DNA Repair
DNA Repair Enzymes
/ genetics
Gene Expression Regulation, Neoplastic
Humans
Male
Mice
Mice, Inbred C57BL
Prognosis
Prostatic Neoplasms
/ genetics
Tumor Cells, Cultured
Ubiquitin Thiolesterase
/ genetics
Xenograft Model Antitumor Assays
Journal
Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R
Informations de publication
Date de publication:
01 02 2020
01 02 2020
Historique:
received:
29
03
2019
revised:
02
10
2019
accepted:
13
11
2019
pubmed:
20
11
2019
medline:
18
8
2020
entrez:
20
11
2019
Statut:
ppublish
Résumé
Emerging evidence indicates the deubiquitinase USP22 regulates transcriptional activation and modification of target substrates to promote pro-oncogenic phenotypes. Here,
Identifiants
pubmed: 31740444
pii: 0008-5472.CAN-19-1033
doi: 10.1158/0008-5472.CAN-19-1033
pmc: PMC7814394
mid: NIHMS1544174
doi:
Substances chimiques
Biomarkers, Tumor
0
Ubiquitin Thiolesterase
EC 3.4.19.12
Usp22 protein, human
EC 3.4.19.12
DNA Repair Enzymes
EC 6.5.1.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
430-443Subventions
Organisme : NCI NIH HHS
ID : F32 CA156989
Pays : United States
Organisme : NCI NIH HHS
ID : F99 CA212225
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA217329
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA182569
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA176401
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA056036
Pays : United States
Informations de copyright
©2019 American Association for Cancer Research.
Références
Oncol Res. 2017 May 24;25(5):743-751
pubmed: 27983930
J Gastroenterol Hepatol. 2010 Nov;25(11):1800-5
pubmed: 21039844
Nucleic Acids Res. 2007;35(16):5338-50
pubmed: 17693435
Cell Cycle. 2013 Feb 15;12(4):698-704
pubmed: 23343766
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9298-E9307
pubmed: 30224477
Nature. 1995 Sep 14;377(6545):162-5
pubmed: 7675084
Mol Cell. 2008 Jan 18;29(1):102-11
pubmed: 18206973
Nat Rev Mol Cell Biol. 2013 Apr;14(4):197-210
pubmed: 23486281
J Cancer Res Clin Oncol. 2011 Aug;137(8):1245-53
pubmed: 21691749
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Commun. 2018 Mar 8;9(1):1006
pubmed: 29520062
Nat Rev Cancer. 2011 Oct 07;11(11):792-804
pubmed: 21979307
Cell Rep. 2018 Jan 9;22(2):383-395
pubmed: 29320735
Cell Rep. 2016 May 17;15(7):1554-1565
pubmed: 27160905
Nucleic Acids Res. 2005 Jul 19;33(13):4023-34
pubmed: 16030353
Nat Cell Biol. 2012 Oct;14(10):1089-98
pubmed: 23000965
Cancer Res. 2007 Mar 15;67(6):2526-34
pubmed: 17363570
DNA Repair (Amst). 2012 Dec 1;11(12):976-85
pubmed: 23099010
Eur Urol. 2019 Sep;76(3):329-337
pubmed: 30777372
Nat Rev Cancer. 2001 Oct;1(1):22-33
pubmed: 11900249
Nat Immunol. 2019 Jun;20(6):747-755
pubmed: 31061531
Cell. 2005 May 6;121(3):387-400
pubmed: 15882621
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Mol Cell. 2009 Aug 14;35(3):352-64
pubmed: 19683498
Cancer Res. 2009 Mar 15;69(6):2210-8
pubmed: 19258514
Cancer Res. 2004 Mar 15;64(6):2270-305
pubmed: 15026373
DNA Repair (Amst). 2009 Apr 5;8(4):536-43
pubmed: 19231300
J Clin Invest. 2005 Jun;115(6):1503-21
pubmed: 15931389
Onco Targets Ther. 2016 Nov 24;9:6987-6998
pubmed: 27920552
J Biol Chem. 2014 Sep 26;289(39):27278-27289
pubmed: 25118285
Mutat Res. 1997 Mar 4;374(1):1-9
pubmed: 9067411
Prostate Cancer. 2011;2011:895238
pubmed: 22111002
Mol Cell Proteomics. 2012 May;11(5):187-201
pubmed: 22322096
Cancer Res. 2014 Jan 1;74(1):272-86
pubmed: 24197134
Curr Protoc Bioinformatics. 2009 Dec;Chapter 13:Unit 13.3
pubmed: 19957274
Nat Protoc. 2006;1(5):2315-9
pubmed: 17406473
Mol Cell. 2012 May 25;46(4):484-94
pubmed: 22542455
PLoS One. 2017 Dec 13;12(12):e0189744
pubmed: 29236775
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Sci Rep. 2015 Jun 04;5:10984
pubmed: 26042670
Nat Biotechnol. 2005 Jan;23(1):94-101
pubmed: 15592455
Genes Cancer. 2010 Jun;1(6):617-28
pubmed: 21779461
Nat Commun. 2015 Jul 07;6:7499
pubmed: 26151477
Eur J Histochem. 2012 Nov 30;56(4):e46
pubmed: 23361242
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nucleic Acids Res. 2007;35(11):3535-50
pubmed: 17483520
Mol Cell. 2016 May 19;62(4):558-71
pubmed: 27132940
Cancer Cell. 2003 Sep;4(3):223-38
pubmed: 14522256
Cancer Cell. 2015 Jul 13;28(1):97-113
pubmed: 26175416
Cancer Discov. 2013 Nov;3(11):1254-71
pubmed: 24027197
Oncotarget. 2015 Nov 10;6(35):37906-18
pubmed: 26431380
J Biol Chem. 2006 Sep 15;281(37):27117-25
pubmed: 16849332
Oncol Rep. 2014 Dec;32(6):2726-34
pubmed: 25241857
Proteomes. 2015 Aug 07;3(3):160-183
pubmed: 28248267
J Biol Chem. 2012 Jan 6;287(2):1527-37
pubmed: 22128178
J Surg Oncol. 2011 Mar 1;103(3):283-9
pubmed: 21337558
Cancer Metastasis Rev. 2014 Sep;33(2-3):377-97
pubmed: 24452759
Oncotarget. 2015 May 20;6(14):12654-67
pubmed: 25909224
Oncotarget. 2017 Oct 29;8(57):96522-96535
pubmed: 29228550
Oncogene. 2018 Apr;37(16):2165-2180
pubmed: 29379164